Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.
- DOI
- 10.1186/s13063-026-09520-x
- Published
- 2026 Mar 24
- Container
- Trials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-026-09520-x,
title = {Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.},
author = {Murphy K and Nel JS and Moosa MY and Wilson DP and Tsitsi M and Mfinanga S and Kivuyo S and Kyazze D and Alam N and Meintjes G and Eriksson M and Adams J and Menezes C and Variava E and Black J and Bremer M and Dat VQ and Le T and Schutz C and Loyse A and Wake RM and Lawrence DS and Wang D and Jaffar S and Jarvis JN and Harrison TS and Molloy SF and Govender NP},
year = {2026},
journal = {Trials},
doi = {10.1186/s13063-026-09520-x},
url = {https://doi.org/10.1186/s13063-026-09520-x}
}RIS
TY - JOUR TI - Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial. AU - Murphy K AU - Nel JS AU - Moosa MY AU - Wilson DP AU - Tsitsi M AU - Mfinanga S AU - Kivuyo S AU - Kyazze D AU - Alam N AU - Meintjes G AU - Eriksson M AU - Adams J AU - Menezes C AU - Variava E AU - Black J AU - Bremer M AU - Dat VQ AU - Le T AU - Schutz C AU - Loyse A AU - Wake RM AU - Lawrence DS AU - Wang D AU - Jaffar S AU - Jarvis JN AU - Harrison TS AU - Molloy SF AU - Govender NP PY - 2026 JO - Trials DO - 10.1186/s13063-026-09520-x UR - https://doi.org/10.1186/s13063-026-09520-x ER -
APA
K, M., JS, N., MY, M., DP, W., M, T., S, M., S, K., D, K., N, A., G, M., M, E., J, A., C, M., E, V., J, B., M, B., VQ, D., T, L., C, S., A, L., RM, W., DS, L., D, W., S, J., JN, J., TS, H., SF, M., & NP, G. (2026). Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.. Trials. https://doi.org/10.1186/s13063-026-09520-x
Source records
- pubmed · retrieved 2026-09-26T13:16:58.088Z